Drug & intervention

lenacapavir

RxCUI 2625651

Clinical trials4

Recruiting3

Related conditions4

Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…

Clinical trials

4 shown

Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral TherapyNCT07682961 · 2026-07-14

Mobile Vehicle-Based Delivery of Lenacapavir Pre-Exposure Prophylaxis in Los Angeles CountyNCT07467018 · 2026-04-21

Lenacapavir Intensification to Disrupt HIV Reservoirs in Virologically Suppressed People With HIV Receiving Antiretroviral TherapyNCT06819176 · 2026-01-20

Study to Evaluate Safety, Pharmacokinetics, and Antiviral Activity of Lenacapavir Administered Subcutaneously in Human Immunodeficiency Virus (HIV) -1 Infected AdultsNCT03739866 · 2018-11-26

Conditions being studied

HIV Infections1 HIV Prevention1 HIV-1 Infection1 Human Immunodeficiency Virus1

Research locations

DallasTexas, United States2 OrlandoFlorida, United States2 West Palm BeachFlorida, United States2 AtlantaGeorgia, United States1 BethesdaMaryland, United States1 Fort LauderdaleFlorida, United States1 Fort WorthTexas, United States1 HoustonTexas, United States1 Kansas CityMissouri, United States1 Los AngelesCalifornia, United States1 OsakaJapan1 SacramentoCalifornia, United States1

Leading sponsors

Gilead Sciences2 National Institute of Allergy and Infectious Diseases (NIAID)1 University of California, Los Angeles1

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.